Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHO-IN CKD PK study
jRCTs061220072Completed
- Start
- Dec 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dantrolene in chronic kidney disease (CKD). Primary endpoint: Pharmacokinetics. Started Dec 2022; status: completed.
02
Drugs
dantrolene
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCTs061220072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220072.